{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:37:42Z","timestamp":1784763462420,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T00:00:00Z","timestamp":1505260800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s11255-017-1696-6","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T15:43:17Z","timestamp":1505317397000},"page":"2119-2125","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The impact of a family history of prostate cancer on the prognosis and features of the disease in Korea: results from a cross-sectional longitudinal pilot study"],"prefix":"10.1007","volume":"49","author":[{"given":"Kwang Suk","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyo Chul","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Ha","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,13]]},"reference":[{"key":"1696_CR1","first-page":"E274","volume":"189","author":"SH Lee","year":"2013","unstructured":"Lee SH, Kim KH, Park KK et al (2013) Can a microfocal prostate cancer be regarded as low risk prostate cancer? J Urol 189:E274","journal-title":"J Urol"},{"key":"1696_CR2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4143\/crt.2015.060","volume":"47","author":"KW Jung","year":"2015","unstructured":"Jung KW, Won YJ, Kong HJ et al (2015) Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat 47:127\u2013141","journal-title":"Cancer Res Treat"},{"key":"1696_CR3","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.eururo.2012.02.054","volume":"61","author":"MM Center","year":"2012","unstructured":"Center MM, Jemal A, Lortet-Tieulent J et al (2012) International variation in prostate cancer incidence and mortality rates. Eur Urol 61:1079","journal-title":"Eur Urol"},{"key":"1696_CR4","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ejca.2004.12.033","volume":"41","author":"HG Sim","year":"2005","unstructured":"Sim HG, Cheng CWS (2005) Changing demography of prostate cancer in Asia. Eur J Cancer 41:834","journal-title":"Eur J Cancer"},{"issue":"Suppl 2","key":"1696_CR5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1365-2605.2000.00009.x","volume":"23","author":"T Fukagai","year":"2000","unstructured":"Fukagai T, Shimada M, Yoshida H et al (2000) Clinical-pathological comparison of clinical prostate cancer between Japanese Americans in Hawaii and Japanese living in Japan. Int J Androl 23(Suppl 2):43","journal-title":"Int J Androl"},{"key":"1696_CR6","doi-asserted-by":"crossref","first-page":"6913","DOI":"10.7314\/APJCP.2013.14.11.6913","volume":"14","author":"DI Kang","year":"2013","unstructured":"Kang DI, Chung JI, Ha HK et al (2013) Korean prostate cancer patients have worse disease characteristics than their American counterparts. Asian Pac J Cancer Prev 14:6913","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2 Pt 1","key":"1696_CR7","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0022-5347(01)67063-0","volume":"154","author":"AG Aprikian","year":"1995","unstructured":"Aprikian AG, Bazinet M, Plante M et al (1995) Family history and the risk of prostatic carcinoma in a high risk group of urological patients. J Urol 154(2 Pt 1):404","journal-title":"J Urol"},{"key":"1696_CR8","first-page":"737","volume":"44","author":"O Cussenot","year":"1996","unstructured":"Cussenot O, Valeri A, Meria P et al (1996) Genetic aspects in cancers of the prostate. Pathol Biol (Paris) 44:737","journal-title":"Pathol Biol (Paris)"},{"key":"1696_CR9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1017\/S1120962300020606","volume":"5","author":"L Gianferrari","year":"1956","unstructured":"Gianferrari L, Arrigoni G, Cresseri A et al (1956) Genetic and clinico-statistical research on neoplasms of the prostate. Acta Genet Med Gemellol (Roma) 5:224","journal-title":"Acta Genet Med Gemellol (Roma)"},{"key":"1696_CR10","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/S0022-5347(05)00698-1","volume":"175","author":"S Roemeling","year":"2006","unstructured":"Roemeling S, Roobol MJ, de Vries SH et al (2006) Prevalence, treatment modalities and prognosis of familial prostate cancer in a screened population. J Urol 175:1332","journal-title":"J Urol"},{"issue":"2","key":"1696_CR11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s13187-016-0991-8","volume":"32","author":"BF Morrison","year":"2017","unstructured":"Morrison BF, Aiken WD, Mayhew R, Gordon Y, Odedina FT (2017) Prostate cancer knowledge, prevention, and screening behaviors in Jamaican men. J Cancer Educ 32(2):352\u2013356","journal-title":"J Cancer Educ"},{"key":"1696_CR12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM200007133430201","volume":"343","author":"P Lichtenstein","year":"2000","unstructured":"Lichtenstein P, Holm NV, Verkasalo PK et al (2000) Environmental and heritable factors in the causation of cancer\u2014analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78","journal-title":"N Engl J Med"},{"key":"1696_CR13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1046\/j.1464-410X.2003.04232.x","volume":"91","author":"LE Johns","year":"2003","unstructured":"Johns LE, Houlston RS (2003) A systematic review and meta-analysis of familial prostate cancer risk. BJU Int 91:789","journal-title":"BJU Int"},{"key":"1696_CR14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ijc.11466","volume":"107","author":"DW Bruner","year":"2003","unstructured":"Bruner DW, Moore D, Parlanti A et al (2003) Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. Int J Cancer 107:797","journal-title":"Int J Cancer"},{"key":"1696_CR15","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/ijc.29243","volume":"136","author":"L Saarimaki","year":"2015","unstructured":"Saarimaki L, Tammela TL, Maattanen L et al (2015) Family history in the finnish prostate cancer screening trial. Int J Cancer 136:2172","journal-title":"Int J Cancer"},{"key":"1696_CR16","doi-asserted-by":"crossref","first-page":"f2023","DOI":"10.1136\/bmj.f2023","volume":"346","author":"AJ Vickers","year":"2013","unstructured":"Vickers AJ, Ulmert D, Sjoberg DD et al (2013) Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40\u201355 and long term risk of metastasis: case-control study. BMJ 346:f2023","journal-title":"BMJ"},{"key":"1696_CR17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4111\/kju.2011.52.1.9","volume":"52","author":"SH Lee","year":"2011","unstructured":"Lee SH, Park KK, Chung MS et al (2011) Clinical features of familial or hereditary prostate cancer in korean men: a pilot study. Korean J Urol 52:9","journal-title":"Korean J Urol"},{"key":"1696_CR18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.6004\/jnccn.2016.0004","volume":"14","author":"JL Mohler","year":"2016","unstructured":"Mohler JL, Armstrong AJ, Bahnson RR et al (2016) Prostate cancer, version 1.2016. J Natl Compr Cancer Netw 14:19","journal-title":"J Natl Compr Cancer Netw"},{"key":"1696_CR19","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/jnci\/djp122","volume":"101","author":"MR Cooperberg","year":"2009","unstructured":"Cooperberg MR, Broering JM, Carroll PR (2009) Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis. J Natl Cancer Inst 101:878","journal-title":"J Natl Cancer Inst"},{"key":"1696_CR20","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.ejca.2011.10.002","volume":"48","author":"MM Heck","year":"2012","unstructured":"Heck MM, Kron M, Gschwend JE et al (2012) Effect of family history on outcome in German patients treated with radical prostatectomy for clinically localised prostate cancer. Eur J Cancer 48:1312","journal-title":"Eur J Cancer"},{"key":"1696_CR21","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0090-4295(03)00033-5","volume":"61","author":"AR Azzouzi","year":"2003","unstructured":"Azzouzi AR, Valeri A, Cormier L et al (2003) Familial prostate cancer cases before and after radical prostatectomy do not show any aggressiveness compared with sporadic cases. Urology 61:1193","journal-title":"Urology"},{"key":"1696_CR22","doi-asserted-by":"crossref","first-page":"10544","DOI":"10.1038\/srep10544","volume":"5","author":"OA Raheem","year":"2015","unstructured":"Raheem OA, Cohen SA, Parsons JK et al (2015) A family history of lethal prostate cancer and risk of aggressive prostate cancer in patients undergoing radical prostatectomy. Sci Rep 5:10544","journal-title":"Sci Rep"},{"key":"1696_CR23","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/bju.13310","volume":"117","author":"M Randazzo","year":"2016","unstructured":"Randazzo M, Muller A, Carlsson S et al (2016) A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau). BJU Int 117:576","journal-title":"BJU Int"},{"key":"1696_CR24","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/978-1-60327-492-0_21","volume":"472","author":"H Williams","year":"2009","unstructured":"Williams H, Powell IJ (2009) Epidemiology, pathology, and genetics of prostate cancer among African Americans compared with other ethnicities. Methods Mol Biol 472:439","journal-title":"Methods Mol Biol"},{"key":"1696_CR25","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.juro.2010.01.015","volume":"183","author":"IJ Powell","year":"2010","unstructured":"Powell IJ, Bock CH, Ruterbusch JJ et al (2010) Evidence supports a faster growth rate and\/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity. J Urol 183:1792","journal-title":"J Urol"},{"key":"1696_CR26","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1080\/0284186X.2016.1191667","volume":"55","author":"FB Thomsen","year":"2016","unstructured":"Thomsen FB, Mikkelsen MK, Hansen RB et al (2016) Clinical characteristics and primary management of patients diagnosed with prostate cancer between 2007 and 2013: status from a Danish primary referral center. Acta Oncol 55:1456","journal-title":"Acta Oncol"},{"key":"1696_CR27","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1200\/JCO.2009.26.0133","volume":"28","author":"MR Cooperberg","year":"2010","unstructured":"Cooperberg MR, Broering JM, Carroll PR (2010) Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 28:1117","journal-title":"J Clin Oncol"},{"key":"1696_CR28","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.6004\/jnccn.2014.0120","volume":"12","author":"PR Carroll","year":"2014","unstructured":"Carroll PR, Parsons JK, Andriole G et al (2014) Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines. J Natl Compr Cancer Netw 12:1211","journal-title":"J Natl Compr Cancer Netw"},{"key":"1696_CR29","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.urology.2012.10.080","volume":"81","author":"JJ Tomaszewski","year":"2013","unstructured":"Tomaszewski JJ, Chen YF, Bertolet M et al (2013) Obesity is not associated with aggressive pathologic features or biochemical recurrence after radical prostatectomy. Urology 81:992\u2013996","journal-title":"Urology"},{"key":"1696_CR30","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s11255-014-0729-7","volume":"46","author":"KC Koo","year":"2014","unstructured":"Koo KC, Yoon YE, Rha KH et al (2014) Low body mass index is associated with adverse oncological outcomes following radical prostatectomy in Korean prostate cancer patients. Int Urol Nephrol 46:1935\u20131940","journal-title":"Int Urol Nephrol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-017-1696-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-017-1696-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-017-1696-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T07:53:58Z","timestamp":1509609238000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-017-1696-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,13]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1696"],"URL":"https:\/\/doi.org\/10.1007\/s11255-017-1696-6","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,13]]}}}